| This article has been cited by |
| 1 | Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes | |
| Ai-Yu Yang,Hung-Chun Chen,Maria Mirabelli |
| Journal of Diabetes Research.2022;2022()1 |
| [DOI] |
|
| 2 | A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control | |
| Tadashi Arao,Yosuke Okada,Akira Kurozumi,Yoshiya Tanaka |
| Cureus.2023;2022()1 |
| [DOI] |
|
| 3 | Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions | |
| Andrew P. Demidowich,Kristine Batty,Mihail Zilbermint |
| Diabetes Spectrum.2022;35(4)440 |
| [DOI] |
|
